The Liverpool star has been bulldozing through the record books and became their joint-third-highest scorer ever in the 2-0 ...
ORLADEYO net revenue of $124.2 million for Q4 2024 (+36.6 percent y-o-y) and $437.7 million for FY 2024 (+34.3 percent y-o-y)——FY 2025 ORLADEYO ...
Clinical trials planned to begin patient enrollment during 2025 to evaluate Gylden’s T cell Priming (TcP) candidates against Dengue (Phase II) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback